drugset / Trial / NCT02319486

CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma

NCT02319486

Phase 4 Completed 26 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate a uniform chemotherapy protocol for nonmetastatic extraocular retinoblastoma

Timeline

Start
2009-01
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 20 mg Other
Subject Carboplatin Small molecule 560 mg/m2 Other
Background Etoposide Small molecule 150 mg/m2
Background Vincristine Small molecule 1.5 mg/m2

Indications